FLI1 and neoplasm: As we have recently identified EWS-FLI1 turnover as an important regulatory event in Ewing sarcoma35, we aimed at identifying potential stabilizers of the fusion protein, and utilize their inhibition which consequently would result in EWS-FLI1 degradation and tumor depletion.